{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:42:58Z","timestamp":1779334978742,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00380-018-1191-8","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T11:43:51Z","timestamp":1526989431000},"page":"1301-1310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association of plasma pentraxin-3 levels with coronary risk factors and the lipid profile: a cross-sectional study in Japanese patients with stable angina pectoris"],"prefix":"10.1007","volume":"33","clinical-trial-number":[{"clinical-trial-number":"umin000023837","registry":"10.18810\/umin-japan"}],"author":[{"given":"Tetsuji","family":"Morishita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Uzui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitomo","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Amaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Kaseno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Dae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"1191_CR1","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1182\/blood.V87.5.1862.1862","volume":"87","author":"M Introna","year":"1996","unstructured":"Introna M, Alles VV, Castellano M, Picardi G, De Gioia L, Bottazzai B, Peri G, Breviario F, Salmona M, De Gregorio L, Dragani TA, Srinivasan N, Blundell TL, Hamilton TA, Mantovani A (1996) Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood 87:1862\u20131872","journal-title":"Blood"},{"key":"1191_CR2","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1161\/01.ATV.0000015595.95497.2F","volume":"22","author":"MS Rolph","year":"2002","unstructured":"Rolph MS, Zimmer S, Bottazzi B, Garlanda C, Mantovani A, Hansson GK (2002) Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler Thromb Vasc Biol 22:e10\u2013e14","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1191_CR3","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1007\/s00380-017-0962-y","volume":"32","author":"H Katoh","year":"2017","unstructured":"Katoh H, Nozue T, Michishita I (2017) Anti-inflammatory effect of factor-Xa inhibitors in Japanese patients with atrial fibrillation. Heart Vessels 32:1130\u20131136","journal-title":"Heart Vessels"},{"key":"1191_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00380-015-0724-7","volume":"31","author":"T Hashikata","year":"2016","unstructured":"Hashikata T, Yamaoka-Tojo M, Kakizaki R, Nemoto T, Fujiyoshi K, Namba S, Kitasato L, Hashimoto T, Kameda R, Maekawa E, Shimohama T, Tojo T, Ako J (2016) Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes. Heart Vessels 31:1303\u20131310","journal-title":"Heart Vessels"},{"key":"1191_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/01.ATV.0000252126.48375.d5","volume":"27","author":"K Inoue","year":"2007","unstructured":"Inoue K, Sugiyama A, Reid PC, Ito Y, Miyauchi K, Mukai S, Sagara M, Miyamoto K, Satoh H, Kohno I, Kurata T, Ota H, Mantovani A, Hamakubo T, Daida H, Kodama T (2007) Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol 27:161\u2013167","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1191_CR6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jcin.2013.04.024","volume":"6","author":"S Koga","year":"2013","unstructured":"Koga S, Ikeda S, Yoshida T, Nakata T, Takeno M, Masuda N, Koide Y, Kawano H, Maemura K (2013) Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound. JACC Cardiovasc Interv 6:945\u2013954","journal-title":"JACC Cardiovasc Interv"},{"key":"1191_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/1753944715578405","volume":"9","author":"M George","year":"2015","unstructured":"George M, Shanmugam E, Srivatsan V, Vasanth K, Ramraj B, Rajaram M, Jena A, Sridhar A, Chaudhury M, Kaliappan I (2015) Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study. Ther Adv Cardiovasc Dis 9:275\u2013284","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"1191_CR8","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1177\/2047487315619733","volume":"23","author":"\u00d8 Mjelva","year":"2016","unstructured":"Mjelva \u00d8, P\u00f6nitz V, Br\u00fcgger-Andersen T, Grundt H, Staines H, Nilsen DW (2016) Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome. Eur J Prev Cardiol 23:1130\u20131140","journal-title":"Eur J Prev Cardiol"},{"key":"1191_CR9","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1161\/01.CIR.0000145167.30987.2E","volume":"110","author":"R Latini","year":"2004","unstructured":"Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, Vago L, Pasqualini F, Signorini S, Soldateschi D, Tarli L, Schweiger C, Fresco C, Cecere R, Tognoni G, Mantovani A, Investigators LATINL (2004) Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 110:2349\u20132354","journal-title":"Circulation"},{"key":"1191_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ahj.2007.08.013","volume":"155","author":"S Suzuki","year":"2008","unstructured":"Suzuki S, Takeishi Y, Niizeki T, Koyama Y, Kitahara T, Sasaki T, Sagara M, Kubota I (2008) Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Am Heart J 155:75\u201381","journal-title":"Am Heart J"},{"key":"1191_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jacc.2010.10.018","volume":"57","author":"J Matsubara","year":"2011","unstructured":"Matsubara J, Sugiyama S, Nozaki T, Sugamura K, Konishi M, Ohba K, Matsuzawa Y, Akiyama E, Yamamoto E, Sakamoto K, Nagayoshi Y, Kaikita K, Sumida H, Kim-Mitsuyama S, Ogawa H (2011) Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction. J Am Coll Cardiol 57:861\u2013869","journal-title":"J Am Coll Cardiol"},{"key":"1191_CR12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1161\/CIRCULATIONAHA.108.806547","volume":"120","author":"GD Norata","year":"2009","unstructured":"Norata GD, Marchesi P, Pulakazhi Venu VK, Pasqualini F, Anselmo A, Moalli F, Pizzitola I, Garlanda C, Mantovani A, Catapano AL (2009) Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 120:699\u2013708","journal-title":"Circulation"},{"key":"1191_CR13","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/CIRCULATIONAHA.107.749234","volume":"117","author":"M Salio","year":"2008","unstructured":"Salio M, Chimenti S, De Angelis N, Molla F, Maina V, Nebuloni M, Pasqualini F, Latini R, Garlanda C, Mantovani A (2008) Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 117:1055\u20131064","journal-title":"Circulation"},{"key":"1191_CR14","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1161\/ATVBAHA.107.160606","volume":"28","author":"GD Norata","year":"2008","unstructured":"Norata GD, Marchesi P, Pirillo A, Uboldi P, Chiesa G, Maina V, Garlanda C, Mantovani A, Catapano AL (2008) Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol 28:925\u2013931","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1191_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1161\/ATVBAHA.108.163204","volume":"28","author":"Z Mallat","year":"2008","unstructured":"Mallat Z, Tedgui A (2008) HDL, PTX3, and vascular protection. Arterioscler Thromb Vasc Biol 28:809\u2013811","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1191_CR16","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1161\/01.CIR.0000120707.98922.E3","volume":"109","author":"W Koenig","year":"2004","unstructured":"Koenig W, L\u00f6wel H, Baumert J, Meisinger C (2004) C-reactive protein modulates risk prediction based on the Framingham score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 109:1349\u20131353","journal-title":"Circulation"},{"key":"1191_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","volume":"107","author":"PM Ridker","year":"2003","unstructured":"Ridker PM, Buring JE, Cook NR, Rifai N (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107:391\u2013397","journal-title":"Circulation"},{"key":"1191_CR18","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0735-1097(99)00574-4","volume":"35","author":"DA Morrow","year":"2000","unstructured":"Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E (2000) Serum amyloid A predicts early mortality in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol 35:358\u2013362","journal-title":"J Am Coll Cardiol"},{"key":"1191_CR19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1161\/01.CIR.0000115516.54550.B1","volume":"109","author":"BD Johnson","year":"2004","unstructured":"Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, Pepine CJ, Sharaf B, Bairey Merz CN, Sopko G, Olson MB, Reis SE, National Heart Ln, and Blood Institute (2004) Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-sponsored women\u2019s ischemia syndrome evaluation (WISE). Circulation 109:726\u2013732","journal-title":"Circulation"},{"key":"1191_CR20","first-page":"3007","volume":"36","author":"S Zewinger","year":"2015","unstructured":"Zewinger S, Drechsler C, Kleber ME, Dressel A, Riffel J, Triem S, Lehmann M, Kopecky C, S\u00e4emann MD, Lepper PM, Silbernagel G, Scharnagl H, Ritsch A, Thorand B, de Las Heras Gala T, Wagenpfeil S, Koenig W, Peters A, Laufs U, Wanner C, Fliser D, Speer T, M\u00e4rz W (2015) Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk. Eur Heart J 36:3007\u20133016","journal-title":"Eur Heart J"},{"key":"1191_CR21","doi-asserted-by":"publisher","first-page":"920517","DOI":"10.1155\/2012\/920517","volume":"2012","author":"P Kunes","year":"2012","unstructured":"Kunes P, Holubcova Z, Kolackova M, Krejsek J (2012) Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response. Mediat Inflamm 2012:920517","journal-title":"Mediat Inflamm"},{"key":"1191_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12979-016-0080-1","volume":"13","author":"F Fornai","year":"2016","unstructured":"Fornai F, Carrizzo A, Forte M, Ambrosio M, Damato A, Ferrucci M, Biagioni F, Busceti C, Puca AA, Vecchione C (2016) The inflammatory protein pentraxin 3 in cardiovascular disease. Immun Ageing 13:25","journal-title":"Immun Ageing"},{"key":"1191_CR23","doi-asserted-by":"publisher","first-page":"490","DOI":"10.5551\/jat.No613","volume":"16","author":"H Ohbayashi","year":"2009","unstructured":"Ohbayashi H, Miyazawa C, Miyamoto K, Sagara M, Yamashita T, Onda R (2009) Pitavastatin improves plasma pentraxin 3 and arterial stiffness in atherosclerotic patients with hypercholesterolemia. J Atheroscler Thromb 16:490\u2013500","journal-title":"J Atheroscler Thromb"},{"key":"1191_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/1475-2840-12-167","volume":"12","author":"R Barazzoni","year":"2013","unstructured":"Barazzoni R, Aleksova A, Carriere C, Cattin MR, Zanetti M, Vinci P, Stolfo D, Guarnieri G, Sinagra G (2013) Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome. Cardiovasc Diabetol 12:167","journal-title":"Cardiovasc Diabetol"},{"key":"1191_CR25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/ATVBAHA.108.178947","volume":"29","author":"NS Jenny","year":"2009","unstructured":"Jenny NS, Arnold AM, Kuller LH, Tracy RP, Psaty BM (2009) Associations of pentraxin 3 with cardiovascular disease and all-cause death: the cardiovascular health study. Arterioscler Thromb Vasc Biol 29:594\u2013599","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1191_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.5551\/jat.10074","volume":"19","author":"T Morishita","year":"2012","unstructured":"Morishita T, Uzui H, Nakano A, Mitsuke Y, Geshi T, Ueda T, Lee JD (2012) Number of endothelial progenitor cells in peripheral artery disease as a marker of severity and association with pentraxin-3, malondialdehyde-modified low-density lipoprotein and membrane type-1 matrix metalloproteinase. J Atheroscler Thromb 19:149\u2013158","journal-title":"J Atheroscler Thromb"},{"key":"1191_CR27","doi-asserted-by":"publisher","first-page":"e001359","DOI":"10.1161\/JAHA.114.001359","volume":"4","author":"T Morishita","year":"2015","unstructured":"Morishita T, Uzui H, Mitsuke Y, Arakawa K, Amaya N, Kaseno K, Ishida K, Nakaya R, Lee JD, Tada H (2015) Predictive utility of the changes in matrix metalloproteinase-2 in the early phase for left ventricular reverse remodeling after an acute myocardial infarction. J Am Heart Assoc 4:e001359","journal-title":"J Am Heart Assoc"},{"key":"1191_CR28","first-page":"219","volume":"1","author":"G Sianos","year":"2005","unstructured":"Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention 1:219\u2013227","journal-title":"Eurointervention"},{"key":"1191_CR29","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Group CQW, Committee ASoEsGaS, Echocardiography EAo (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440\u20131463","journal-title":"J Am Soc Echocardiogr"},{"key":"1191_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2215\/CJN.04330808","volume":"4","author":"MI Yilmaz","year":"2009","unstructured":"Yilmaz MI, Axelsson J, Sonmez A, Carrero JJ, Saglam M, Eyileten T, Caglar K, Kirkpantur A, Celik T, Oguz Y, Vural A, Yenicesu M, Lindholm B, Stenvinkel P (2009) Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria. Clin J Am Soc Nephrol 4:535\u2013541","journal-title":"Clin J Am Soc Nephrol"},{"key":"1191_CR31","doi-asserted-by":"publisher","first-page":"e44454","DOI":"10.1371\/journal.pone.0044454","volume":"7","author":"DA Duprez","year":"2012","unstructured":"Duprez DA, Neuhaus J, Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon D, Paton NI, Prineas RJ, Neaton JD, Group ISS (2012) Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One 7:e44454","journal-title":"PLoS One"},{"key":"1191_CR32","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0735-1097(97)00494-4","volume":"31","author":"T Tsutamoto","year":"1998","unstructured":"Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, Mabuchi N, Sawaki M, Kinoshita M (1998) Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31:391\u2013398","journal-title":"J Am Coll Cardiol"},{"key":"1191_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ejheart.2008.02.015","volume":"10","author":"S Frantz","year":"2008","unstructured":"Frantz S, St\u00f6rk S, Michels K, Eigenthaler M, Ertl G, Bauersachs J, Angermann CE (2008) Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality. Eur J Heart Fail 10:388\u2013395","journal-title":"Eur J Heart Fail"},{"key":"1191_CR34","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.atherosclerosis.2006.07.027","volume":"194","author":"PJ Fitzsimmons","year":"2007","unstructured":"Fitzsimmons PJ, Forough R, Lawrence ME, Gantt DS, Rajab MH, Kim H, Weylie B, Spiekerman AM, Dehmer GJ (2007) Urinary levels of matrix metalloproteinase 9 and 2 and tissue inhibitor of matrix metalloproteinase in patients with coronary artery disease. Atherosclerosis 194:196\u2013203","journal-title":"Atherosclerosis"},{"issue":"Supplement 84","key":"1191_CR35","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1046\/j.1523-1755.63.s84.50.x","volume":"63","author":"C Zoccali","year":"2003","unstructured":"Zoccali C, Mallamaci F, Tripepi G (2003) Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease. Kidney Int Suppl 63(Supplement 84):S65\u2013S68","journal-title":"Kidney Int Suppl"},{"key":"1191_CR36","doi-asserted-by":"publisher","first-page":"e53133","DOI":"10.1371\/journal.pone.0053133","volume":"8","author":"S Suzuki","year":"2013","unstructured":"Suzuki S, Shishido T, Funayama A, Netsu S, Ishino M, Kitahara T, Sasaki T, Katoh S, Otaki Y, Watanabe T, Shibata Y, Mantovani A, Takeishi Y, Kubota I (2013) Long pentraxin PTX3 exacerbates pressure overload-induced left ventricular dysfunction. PLoS One 8:e53133","journal-title":"PLoS One"},{"key":"1191_CR37","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/oby.20695","volume":"22","author":"A Witasp","year":"2014","unstructured":"Witasp A, Carrero JJ, Micha\u00eblsson K, Ahlstr\u00f6m H, Kullberg J, Adamsson V, Ris\u00e9rus U, Larsson A, Helmersson-Karlqvist J, Lind L, Stenvinkel P, Arnl\u00f6v J (2014) Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss. Obesity (Silver Spring) 22:1373\u20131379","journal-title":"Obesity (Silver Spring)"},{"key":"1191_CR38","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1161\/01.ATV.0000012282.39306.64","volume":"22","author":"E Napoleone","year":"2002","unstructured":"Napoleone E, Di Santo A, Bastone A, Peri G, Mantovani A, de Gaetano G, Donati MB, Lorenzet R (2002) Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. Arterioscler Thromb Vasc Biol 22:782\u2013787","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-018-1191-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-018-1191-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-018-1191-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T14:18:38Z","timestamp":1628605118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-018-1191-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1191"],"URL":"https:\/\/doi.org\/10.1007\/s00380-018-1191-8","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"10 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}